Abstract

This study evaluated which endometrial preparation protocol in frozen embryo transfer (FET) cycles provides the best results for polycystic ovarian syndrome (PCOS) patients and the general population. This retrospective study of 634 FET cycles was conducted 2016–2018. Cycles were divided into Group A: Artificial endometrial preparations for FET (aFET; n = 348), Group B: Ovulatory cycle (n = 286) to compare two methods of endometrial preparation for FET. Artificial endometrial preparation with exogenous estrogen and progesterone versus natural ovulation cycles, modified natural cycles using hCG for the final triggering and letrozole-induced ovulation with hCG. Anovulatory patients were analyzed separately. Anovulatory PCOS patients had significantly higher pregnancy rates with letrozole treatment compared with aFET cycles (44% vs. 22.5%; p = 0.044). For the entire cohort, ovulatory cycles and aFET were similar in terms of patient characteristics, demographics, infertility causes, treatment protocols and number of embryos transferred. Although the mean ESHRE score of the transferred embryos was higher in the aFET group, we found higher clinical pregnancy rate in the ovulatory cycle FET (41.3% vs. 27.3%, p < 0.0001). A better pregnancy rate was found after ovulatory cycle FET. In the ovulatory cycles, the outcome of letrozole-induced and non-induced cycles were comparable. PCOS patients, as well as the general population, may benefit from ovulation induced FET cycles, with significantly better outcomes in FET in ovulatory cycles.

Highlights

  • Except for more anovulatory patients in the Artificial endometrial preparations for FET (aFET) group, other causes of infertility, fresh cycle characteristics, and number of embryos transferred revealed no significant differences between patients (Table 1)

  • Group (ESHRE score 2.37 ± 0.81 vs. 2.17 ± 0.71, p = 0.031), higher chemical, clinical pregnancy rates, and ongoing pregnancy and delivery rates were achieved in the ovulatory cycle-frozen embryo transfer (FET) group (45.8% vs. 34.2%, p = 0.03; 41.3% vs. 27.3%, p < 0.0001, and 33% vs. 19%, p < 0.0001, respectively; Table 1) and a significantly higher miscarriage rate were observed in the aFET group (54.7% vs. 33%, p < 0.0001)

  • We found that for polycystic ovarian syndrome (PCOS) patients, letrozole-induced treatment outcomes had significantly better pregnancy rates

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. The worldwide shift towards frozen embryo transfer (FET) has accelerated, as more frozen embryos are currently available per patient for future use [1]. Multiple factors contributed to this change, beginning primarily with improved incubators and changes in the mode of embryo preservation towards vitrification, which improved the survival rate and quality of the thawed embryos [2]. The indications for embryo freezing for future use were extended beyond patients with suspected ovarian hyperstimulation syndrome

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call